Chronic Incretin-based therapy in Cystic Fibrosis (Aim 2)
Contact
Description
The purpose of this research study is to examine and understand the various mechanisms that contribute to Cystic Fibrosis Related Diabetes and gain a better understanding of potential means to treat Cystic Fibrosis Related Diabetes. Participation will include 6-7 visits over 6 months.
Eligibility and criteria
IRB Number:
13-010324
Eligible age range:
Clinical trial phase:
Phase II
Official title:
We need families like you
Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.